Recombinant Human Nerve Growth Factor Treatment Promotes Photoreceptor Survival in the Retinas of Rats with Retinitis Pigmentosa
- PMID: 28632034
- DOI: 10.1080/02713683.2017.1279634
Recombinant Human Nerve Growth Factor Treatment Promotes Photoreceptor Survival in the Retinas of Rats with Retinitis Pigmentosa
Abstract
Purpose: Increasing evidence suggests that nerve growth factor (NGF) exerts protective effects against retinal degeneration in animal models of retinitis pigmentosa (RP). This study aims at investigating the effects of intravitreal injection of recombinant human NGF (rhNGF) on retinal photoreceptors apoptosis in an animal model of RP, the Royal College of Surgeons (RCS) rats.
Methods: Thirty-six RCS rats were treated with intravitreal injection of rhNGF or murine NGF (mNGF) or vehicle at 20 postnatal days (pd) and sacrificed at 40 pd. The eyes were enucleated and evaluated by histology, flow cytometric analysis for rhodopsin expression, Western blot for TrkA and activated (phosphorylated) TrkA (pTrkA) levels, and TUNEL assay for apoptosis' detection.
Results: RCS rats showed a significant retinal degeneration associated with cell apoptosis at 40 pd when compared to wild-type animals. Histology showed that rhNGF intravitreal treatment significantly increased retinal thickness when compared to untreated eyes. Photoreceptors' number evaluated by flow cytometry was significantly increased in both intravitreal rhNGF- and mNGF-treated groups when compared to untreated eyes. This protective effect was associated with an increase in TrkA and activated pTrkA levels and an inhibition of apoptosis. Intravitreal NGF injection was well tolerated and did not show clinical and histological signs of adverse effects.
Conclusions: Intravitreal rhNGF injection proved safe and effective in favoring retinal cell survival in RCS rats. This is the first report showing that the novel rhNGF already proved safe in a phase I study exerts a biologic effect similar to the well-characterized mNGF-induced retinal protection. These results may trigger further studies to investigate rhNGF administration for the treatment of progressive degenerative retinal disorders such as retinitis pigmentosa.
Keywords: Animal model; apoptosis; nerve growth factor; retinal photoreceptors; retinitis pigmentosa.
Similar articles
-
NGF/anti-VEGF combined exposure protects RCS retinal cells and photoreceptors that underwent a local worsening of inflammation.Graefes Arch Clin Exp Ophthalmol. 2017 Mar;255(3):567-574. doi: 10.1007/s00417-016-3567-8. Epub 2016 Dec 24. Graefes Arch Clin Exp Ophthalmol. 2017. PMID: 28013393
-
Effect of purified murine NGF on isolated photoreceptors of a rodent developing retinitis pigmentosa.PLoS One. 2015 Apr 21;10(4):e0124810. doi: 10.1371/journal.pone.0124810. eCollection 2015. PLoS One. 2015. PMID: 25897972 Free PMC article.
-
Inhibitory peptide of mitochondrial μ-calpain protects against photoreceptor degeneration in rhodopsin transgenic S334ter and P23H rats.PLoS One. 2013 Aug 9;8(8):e71650. doi: 10.1371/journal.pone.0071650. eCollection 2013. PLoS One. 2013. PMID: 23951212 Free PMC article.
-
[New drug therapy for retinal degeneration].Nippon Ganka Gakkai Zasshi. 2008 Jan;112(1):7-21. Nippon Ganka Gakkai Zasshi. 2008. PMID: 18240599 Review. Japanese.
-
Retinitis pigmentosa and retinal degeneration in animals: a review.Can J Biochem Cell Biol. 1984 Jun;62(6):535-46. doi: 10.1139/o84-071. Can J Biochem Cell Biol. 1984. PMID: 6147187 Review.
Cited by
-
Nerve Growth Factor Role on Retinal Ganglion Cell Survival and Axon Regrowth: Effects of Ocular Administration in Experimental Model of Optic Nerve Injury.Mol Neurobiol. 2019 Feb;56(2):1056-1069. doi: 10.1007/s12035-018-1154-1. Epub 2018 Jun 4. Mol Neurobiol. 2019. PMID: 29869196
-
Human NGF "Painless" Ocular Delivery for Retinitis Pigmentosa: An In Vivo Study.eNeuro. 2024 Sep 18;11(9):ENEURO.0096-24.2024. doi: 10.1523/ENEURO.0096-24.2024. Print 2024 Sep. eNeuro. 2024. PMID: 39293937 Free PMC article.
-
Differential effects of antipsychotic drugs on contrast response functions of retinal ganglion cells in wild-type Sprague-Dawley rats and P23H retinitis pigmentosa rats.PLoS One. 2019 Jun 10;14(6):e0218200. doi: 10.1371/journal.pone.0218200. eCollection 2019. PLoS One. 2019. PMID: 31181134 Free PMC article.
-
Nerve Growth Factor-Based Therapy in Alzheimer's Disease and Age-Related Macular Degeneration.Front Neurosci. 2021 Sep 9;15:735928. doi: 10.3389/fnins.2021.735928. eCollection 2021. Front Neurosci. 2021. PMID: 34566573 Free PMC article. Review.
-
Neuroprotective Nanoparticles Targeting the Retina: A Polymeric Platform for Ocular Drug Delivery Applications.Pharmaceutics. 2023 Mar 29;15(4):1096. doi: 10.3390/pharmaceutics15041096. Pharmaceutics. 2023. PMID: 37111581 Free PMC article.
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Other Literature Sources